Default company panoramic image
Logo

Matrix-Bio

MBI provides highly accurate diagnostic blood tests for cancer where inaccurate blood or invasive tissue tests are the current standard.

  • Stage Prototype Ready
  • Industry Medical Devices and Equipment
  • Location West Lafayette, IN, USA
  • Currency USD
  • Employees 2
  • Website matrix-bio.com

Company Summary

Matrix-Bio is a diagnostics service company focused on developing blood based cancer diagnostics using a proprietary and patent-pending Metabolite-Profiling platform technology. Within the next year, MBI will offer a simple blood test for breast cancer recurrence that is significantly more accurate than current monitoring assays. Matrix-Bio is also developing early detection tests to complement mammography, and for colon and esophageal cancers.

Team

  • Default avatar
    Eric Beier, MD, MBA
    CEO

  • Default avatar
    Daniel Raftery, PhD, MBA
    CSO & Founder

  • Default avatar
    Robert Ballas, PhD
    Diagnostics Consultant

Advisors

  • Default avatar
    Jeff Warren, Duxbury MA
    Lawyer
    Unconfirmed
    Default avatar
    Reed & Company, Lafayette, IN
    Accountant
    Unconfirmed

Previous Investors

  • Default avatar
    Main Street Venture Fund, New Mexico Angels|Purdue Emerging Innovation Fund|Daniel Raftery, Ph.D
    Unconfirmed